Fate Therapeutics
FATE
FATE
147 hedge funds and large institutions have $1.41B invested in Fate Therapeutics in 2019 Q4 according to their latest regulatory filings, with 34 funds opening new positions, 58 increasing their positions, 35 reducing their positions, and 30 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
147
Holders Change
-2
Holders Change %
-1.34%
% of All Funds
2.9%
Holding in Top 10
7
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+16.67%
% of All Funds
0.14%
New
34
Increased
58
Reduced
35
Closed
30
Calls
$13.3M
Puts
$8.71M
Net Calls
+$4.6M
Net Calls Change
+$5.14M
Top Buyers
| 1 |
Victory Capital Management
San Antonio,
Texas
|
+$11.2M |
| 2 |
BlackRock
New York
|
+$10.5M |
| 3 |
EC
EcoR1 Capital
San Francisco,
California
|
+$8.83M |
| 4 |
Ameriprise
Minneapolis,
Minnesota
|
+$8.76M |
| 5 |
Morgan Stanley
New York
|
+$7.51M |
Top Sellers
| 1 |
Millennium Management
New York
|
-$34.8M |
| 2 |
PHS
PFM Health Sciences
San Francisco,
California
|
-$13.7M |
| 3 |
AVM
Arch Venture Management
Chicago,
Illinois
|
-$11.1M |
| 4 |
Franklin Resources
San Mateo,
California
|
-$10.9M |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
-$7.78M |
